Prospects Fund

Prospects Oncology Fund

FACIT’s Prospects Fund is designed to support early stage proof-of-concept (POC) studies within Ontario academic institutions and start-ups that fit with FACIT’s Investment Strategy and have the potential to act as deal flow for the IPDC Fund. Awarded grants typically range between $50,000 and $200,000.

Funding is governed by a research contract which grants certain rights to FACIT.   FACIT receives no financial consideration on Prospects grants under $100,000.  On grants of $100,000 or more, FACIT receives an option to make an investment at the IPDC level and act as the agent for commercialization.  If the option is exercised, funding received from the Prospects grant will be credited towards FACIT's IPDC investment.

How to apply:

The Prospects Fund is accepting pre-submission forms twice yearly on the following dates:

  • March 31
  • September 30

The pre-submission form can be downloaded here.

Late applications will not be considered.

Selected applicants will then be invited to prepare a Prospects funding application which is subject to due diligence by FACIT.

Select Prospects Funded Projects

Prospects Fund (Other)

Cell-Mate Technology for Esophageal Cell Sampling

Support for the use of Cell-Mate Technology in a clinical trial for the Genome Canada project entitled "Early detection of patients at high risk of esophageal adenocarcinoma".

Cell-Mate Technology for Esophageal Cell SamplingCell-Mate Technology for Esophageal Cell Sampling


MY-osto-ME Inc.

An economical port, bag and belt system for urostomy patients that aims to reduce their rate of complications, facilitate application, and reduce social stigma; overall helping to improve the quali

MY-osto-ME Inc.MY-osto-ME Inc.


Ultra-Low Dose Microbubbles for Cancer Imaging

A proprietary method to manufacture, store and reconstitute monodisperse and size-tunable, lipid-based microbubbles for ultra-low dose, contrast-enhanced ultrasound.

Ultra-Low Dose Microbubbles for Cancer ImagingUltra-Low Dose Microbubbles for Cancer Imaging


Ring Study to Evaluate the PRedicTive brEast Cancer Test (PRoTECT)

Evaluation of a Nanostring gene expression assay across three centres for its analytical reproducibility and accuracy in potentially guiding the selection of patient-specific therapies for early br

Ring Study to Evaluate the PRedicTive brEast Cancer Test (PRoTECT)Ring Study to Evaluate the PRedicTive brEast Cancer Test (PRoTECT)


View All Prospects Funded Projects